© kentoh Business | December 27, 2017

Fresenius expects material positive effects from US tax reform

Fresenius Medical Care, specialising in dialysis products and services, expects material positive effects from the tax reform legislation signed into law in the United States.
The new law goes into effect on January 1, 2018.

In particular, the new legislation triggers the re-evaluation of deferred tax liabilities. This results in a one-time book gain of around EUR 200 million, to be reflected in 2017 Earnings After Tax, the in Bad Homburg (Germany) headquartered company announced.


Please note the following: Critical comments are allowed and even encouraged. Discussions are welcome. Verbal abuse, insults and racist / homophobic remarks are not. Such comments will be removed.
Further details can be found here.
Load more news
July 18 2018 5:55 pm V10.0.0-1